Hester Biosciences net profit at Rs8.86cr, up by 77% in Q4FY21

The company is able to maintain healthy margins; EBITDA Margin was reported at 32.62% and Net Profit margin at 14.03% in Q4FY21.

from India Infoline News Service https://ift.tt/354xu8i